Commission proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply
In 2017, the EU introduced new rules for medical devices and in vitro diagnostics to ensure a better protection of public health and patient safety. Despite considerable progress in transitioning to these rules and the additional time given to the sector to implement them, the transition remains slow.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 23 January 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (13 février 2024). Commission proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply. ELSIBI. Consulté le 12 janvier 2026 à l’adresse https://doi.org/10.58079/vts4





